Home › Stocks › RLMD

Relmada Therapeutics, Inc. (RLMD): insider buying, hedge funds & Congress trades

Relmada Therapeutics, Inc. (RLMD): 11 insider purchases in the last two years; 2 trades disclosed by members of Congress.

Insider buying

FiledInsiderSharesPriceValueType
Dec 16, 2025Shenouda Maged
Officer
11,665$4.12$48.1Kno history
Dec 16, 2025Traversa Sergio
Director, Officer
27,500$4.12$113.3Kno history
Nov 6, 2025Kelly Paul Edward
Director, Officer
90,000$2.20$198.0Kno history
Nov 6, 2025Shenouda Maged
Officer
500,000$2.20$1.1Mno history
Nov 6, 2025Traversa Sergio
Director, Officer
272,500$2.20$599.5Kno history
Nov 6, 2025Ence Chuck
Officer
136,000$2.20$299.2Kno history
Aug 28, 2025Traversa Sergio
Director, Officer
265,976$0.67$178.1Kno history
May 20, 2025Traversa Sergio
Director, Officer
350,000$0.50$175.2Kno history
May 20, 2025Ence Chuck
Officer
228,961$0.45$103.0Kno history
May 20, 2025Shenouda Maged
Officer
200,000$0.49$97.3Kno history
May 20, 2025Kelly Paul Edward
Director, Officer
200,000$0.43$86.0Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for RLMD

Free account. Know when insiders, famous funds or Congress trade it.

Start free

Congress trades in RLMD

FiledMemberTypeAmount
Jan 20, 2023Christopher L. Jacobssale$1,001 - $15,000
Dec 12, 2022Christopher L. Jacobspurchase$1,001 - $15,000